Print

Curis, Inc. (CRIS) Reports Third Quarter 2012 Financial Results  
11/6/2012 9:34:17 AM

LEXINGTON, Mass., Nov. 6, 2012 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today reported its financial results for the third quarter ended September 30, 2012.
//-->